CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
CYNA was delisted on the 20th of October, 2016.
26 hedge funds and large institutions have $92.8M invested in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in 2015 Q2 according to their latest regulatory filings, with 26 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$18.7M |
| 2 |
BC
Broadfin Capital
New York
|
+$14.4M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$9.84M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$9.84M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$5.19M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Barclays
London,
United Kingdom
| $2K | +$1.84K | +112 | New |
|
27
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | +$164 | +10 | New |
|
CYNA Hedge Fund Activity: Q2 2015 in Review
26 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) for Q2 2015, worth a combined $92.8M.
Buyers outnumbered sellers: 26 funds opened new CYNA positions and 0 closed out — a net gain of 26 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was OrbiMed, opening a new position worth an estimated $18.7M.
- 26 institutional investors held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) as of Q2 2015, up from 0 in Q1 2015.
- Funds reported $92.8M of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) stock for Q2 2015.
- 26 funds opened new CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) positions in Q2 2015 and 0 closed out, a net change of +26 holders.
- The largest CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) buyer in Q2 2015 was OrbiMed, an estimated $18.7M added.
Based on aggregated 13F filings for Q2 2015.